Terns Pharmaceuticals, Inc.
TERNDelisted May 5, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831363
Terns Pharmaceuticals, Inc. was delisted on May 5, 2026; its insiders filed their last Form 4 on May 5, 2026; 317 institutions reported holding it in 13F filings for Q1 2026, worth $6.56B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q4 2022
Institutional positions in Terns Pharmaceuticals, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 65
- +20 vs. Q3 2022
- Shares held
- 49.7M
- +19.4M (+64.2%) vs. Q3 2022
- Total value
- $506.2M
- +$328.1M (+184.2%) vs. Q3 2022
- New holders
- 25
- 23 more added
- Sold out
- 5
- 14 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TERN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $75.4K |
| Q1 2026 | 317 | $6.56B |
| Q4 2025 | 248 | $4.95B |
| Q3 2025 | 141 | $665.7M |
| Q2 2025 | 130 | $310.0M |
| Q1 2025 | 138 | $229.4M |
| Q4 2024 | 157 | $477.2M |
| Q3 2024 | 156 | $663.1M |
| Q2 2024 | 126 | $446.7M |
| Q1 2024 | 112 | $414.8M |
| Q4 2023 | 103 | $412.7M |
| Q3 2023 | 93 | $310.4M |
| Q2 2023 | 103 | $505.0M |
| Q1 2023 | 79 | $630.2M |
| Q4 2022 | 65 | $506.2M |
| Q3 2022 | 45 | $178.1M |
| Q2 2022 | 42 | $36.5M |
| Q1 2022 | 44 | $50.0M |
| Q4 2021 | 37 | $116.7M |
| Q3 2021 | 34 | $174.3M |
| Q2 2021 | 36 | $203.8M |
| Q1 2021 | 42 | $393.7M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Terns Pharmaceuticals, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 7,619,135 | $77.6M | 1.49% | +137,931+1.8% | Added |
| FMR LLC | 7,378,641 | $75.1M | 0.01% | +7,277,002+7,159.7% | Added |
| Vivo Capital, LLC | 6,657,992 | $67.8M | 8.21% | +758,620+12.9% | Added |
| VR Adviser, LLC | 3,707,891 | $37.7M | 6.36% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 3,448,275 | $35.1M | 1.47% | +3,448,275 | New |
| Deerfield Management Company, L.P. (Series C) | 2,851,287 | $29.0M | 0.60% | +991,287+53.3% | Added |
| Driehaus Capital Management LLC | 2,294,376 | $23.4M | 0.35% | +696,447+43.6% | Added |
| Fairmount Funds Management LLC | 2,040,000 | $20.8M | 3.29% | −10,000−0.5% | Reduced |
| Millennium Management LLC | 1,457,205 | $14.8M | 0.02% | +1,074,492+280.8% | Added |
| JPMorgan Chase & Co | 1,207,151 | $12.3M | 0.00% | +288,109+31.3% | Added |
| Vanguard Group Inc | 1,126,036 | $11.5M | 0.00% | +506,904+81.9% | Added |
| Acuta Capital Partners, LLC | 1,100,000 | $11.2M | 6.89% | +749,298+213.7% | Added |
| RTW Investments, LP | 1,000,000 | $10.2M | 0.21% | +1,000,000 | New |
| Franklin Resources Inc | 750,024 | $7.64M | 0.00% | +750,024 | New |
| Ikarian Capital, LLC | 737,319 | $7.51M | 3.11% | −166,800−18.4% | Reduced |
| Decheng Capital Management III (Cayman), LLC | 714,285 | $7.27M | 2.72% | 00.0% | Unchanged |
| Silverarc Capital Management, LLC | 700,000 | $7.13M | 2.45% | +685,527+4,736.6% | Added |
| Pura Vida Investments, LLC | 605,079 | $6.16M | 1.03% | −123,521−17.0% | Reduced |
| Armistice Capital, LLC | 560,000 | $5.70M | 0.15% | −40,000−6.7% | Reduced |
| Barclays PLC | 516,739 | $5.26M | 0.00% | −142,359−21.6% | Reduced |
| Citadel Advisors LLC | 515,797 | $5.25M | 0.01% | +515,797 | New |
| BlackRock Inc. | 299,438 | $3.05M | 0.00% | +13,145+4.6% | Added |
| Point72 Asset Management, L.P. | 233,500 | $2.38M | 0.01% | +233,500 | New |
| Samsara BioCapital, LLC | 202,348 | $2.06M | 0.44% | −86,720−30.0% | Reduced |
| Bank of Montreal | 194,100 | $1.98M | 0.00% | +194,100 | New |
| Geode Capital Management, LLC | 177,648 | $1.81M | 0.00% | +8,800+5.2% | Added |
| Endurant Capital Management LP | 135,994 | $1.38M | 0.56% | +135,994 | New |
| EAM Investors, LLC | 128,186 | $1.30M | 0.27% | +128,186 | New |
| Boothbay Fund Management, LLC | 125,882 | $1.28M | 0.04% | −9,837−7.2% | Reduced |
| Monashee Investment Management LLC | 122,500 | $1.25M | 0.54% | +122,500 | New |
| Renaissance Technologies LLC | 114,900 | $1.17M | 0.00% | −37,300−24.5% | Reduced |
| Polar Asset Management Partners Inc. | 100,000 | $1.02M | 0.01% | +100,000 | New |
| Dimensional Fund Advisors LP | 98,940 | $1.01M | 0.00% | +65,628+197.0% | Added |
| Bridgeway Capital Management, LLC | 92,700 | $943.7K | 0.02% | +23,200+33.4% | Added |
| HighVista Strategies LLC | 77,344 | $787.4K | 0.47% | 00.0% | Unchanged |
| Walleye Capital LLC | 73,611 | $749.4K | 0.02% | +61,487+507.2% | Added |
| Altium Capital Management LP | 70,000 | $712.6K | 0.36% | +70,000 | New |
| State Street Corp | 59,537 | $606.1K | 0.00% | +17,500+41.6% | Added |
| Citigroup Inc | 46,048 | $468.8K | 0.00% | +45,347+6,468.9% | Added |
| Susquehanna International Group, LLP | 38,102 | $387.9K | 0.00% | +38,102 | New |
| Marshall Wace, LLP | 36,081 | $367.3K | 0.00% | +36,081 | New |
| HRT Financial LP | 35,090 | $357.0K | 0.01% | +35,090 | New |
| Northern Trust Corp | 31,593 | $321.6K | 0.00% | +10,089+46.9% | Added |
| 683 Capital Management, LLC | 28,000 | $285.0K | 0.03% | +28,000 | New |
| Alps Advisors Inc | 25,525 | $259.8K | 0.00% | +25,525 | New |
| Acadian Asset Management LLC | 22,599 | $229.0K | 0.00% | +9,972+79.0% | Added |
| Jane Street Group, LLC | 21,507 | $218.9K | 0.00% | +8,252+62.3% | Added |
| Caas Capital Management LP | 20,000 | $203.6K | 0.04% | −65,851−76.7% | Reduced |
| Morgan Stanley | 18,058 | $183.8K | 0.00% | +10,815+149.3% | Added |
| Dynamic Technology Lab Private Ltd | 15,709 | $160.0K | 0.02% | +15,709 | New |
| Crosspoint Financial, LLC | 15,054 | $153.3K | 1.69% | +15,054 | New |
| Man Group plc | 13,763 | $140.1K | 0.00% | +13,763 | New |
| Raymond James & Associates | 12,488 | $127.1K | 0.00% | +12,488 | New |
| Goldman Sachs Group Inc | 10,830 | $110.2K | 0.00% | −1,086−9.1% | Reduced |
| Velan Capital Investment Management LP | 10,646 | $108.4K | 0.12% | +10,646 | New |
| Qube Research & Technologies Ltd | 10,545 | $107.3K | 0.00% | −264−2.4% | Reduced |
| Tower Research Capital LLC (TRC) | 5,539 | $57.0K | 0.00% | −1,062−16.1% | Reduced |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 5,050 | $51.4K | 0.00% | +5,050 | New |
| Cubist Systematic Strategies, LLC | 4,865 | $49.5K | 0.00% | +4,865 | New |
| Bank of America Corp | 1,815 | $18.5K | 0.00% | −5,911−76.5% | Reduced |
| China Universal Asset Management Co., Ltd. | 383 | $3.90K | 0.00% | +30+8.5% | Added |
| Capital Advisors, Ltd. LLC | 188 | $2.00K | 0.00% | −12−6.0% | Reduced |
| Royal Bank of Canada | 182 | $2.00K | 0.00% | +182 | New |
| Daiwa Securities Group Inc. | 151 | $2.00K | 0.00% | +151 | New |
| Wells Fargo & Company | 126 | $1.28K | 0.00% | +4+3.3% | Added |
| Commodore Capital LP | 0 | $0 | 0.00% | −205,870−100.0% | Sold out |
| Raymond James Financial Services Advisors, Inc. | 0 | $0 | 0.00% | −20,830−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −12,408−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −10,945−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −3,667−100.0% | Sold out |